What intramuscular lorazepam dose is recommended for an adult experiencing an acute panic attack when oral administration is not feasible?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intramuscular Lorazepam for Panic Attack

For an adult experiencing an acute panic attack requiring intramuscular administration, give lorazepam 0.05 mg/kg up to a maximum of 4 mg IM. 1

Standard IM Dosing Protocol

The FDA-approved dosing for intramuscular lorazepam as a premedicant (which applies to acute anxiety situations when oral administration is not feasible) is:

  • Standard dose: 0.05 mg/kg IM, maximum 4 mg 1
  • Inject deep into the muscle mass, undiluted 1
  • For optimum anxiolytic effect, IM lorazepam should be administered at least 2 hours before anticipated peak anxiety when possible, though it will work more rapidly in acute situations 1

Important Dosing Considerations

Elderly or Frail Patients

  • Reduce the dose by 20% or more in elderly patients due to reduced clearance 2
  • Start at the lower end of the dosage range for debilitated patients 3

Patients with Respiratory Disease

  • Use lower doses (consider starting at 1-2 mg IM) in patients with COPD or underlying respiratory disease due to increased risk of respiratory depression 3, 2

Critical Safety Monitoring

You must monitor oxygen saturation and respiratory effort during and after administration 2:

  • Be prepared to support ventilation if needed 2
  • Respiratory depression risk increases significantly when combined with opioids or other CNS depressants 2
  • Have reversal agent (flumazenil) available, though use cautiously as it may precipitate seizures in patients with seizure disorders 3

Pharmacokinetic Profile

  • Absorption after IM injection is rapid, with peak plasma levels reached at approximately 1.15 hours 4
  • Absorption half-life averages 14.2 minutes after IM administration 4
  • Absolute bioavailability is 95.9% for IM lorazepam, essentially complete absorption 4
  • Duration of action: 1-24 hours (significantly longer than midazolam) 2

Common Pitfalls to Avoid

Paradoxical agitation: Benzodiazepines may paradoxically worsen agitation in some patients, particularly younger individuals 3, 5. If this occurs, consider switching to an antipsychotic agent.

Underdosing: While 2 mg is commonly used for sedation, panic attacks may require the full 4 mg dose for adequate anxiolysis 1. The 0.05 mg/kg dosing (up to 4 mg maximum) is specifically recommended for situations requiring robust anxiolytic effect 1.

Combining with high-dose antipsychotics: Avoid combining lorazepam with high-dose olanzapine due to reports of fatalities from oversedation and respiratory depression 3, 2.

Alternative Considerations

If IV access becomes available, IV lorazepam 2-4 mg administered slowly over 2-3 minutes may be preferred as it allows for more controlled titration 2. However, IM lorazepam remains highly effective when IV access is not feasible, with near-complete bioavailability 4.

For cooperative patients who can tolerate oral/sublingual administration, sublingual lorazepam 2 mg is completely absorbed (98.2% bioavailability) and may be preferable to IM injection 4.

References

Guideline

Intravenous Lorazepam Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

IV Diazepam Dosing for Acute Anxiety Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.